Rheumatism News and Research

RSS
Rheumatism is a group of disorders marked by inflammation or pain in the connective tissue structures of the body. These structures include bone, cartilage, and fat.

Further Reading

Updated EULAR recommendations for management of rheumatoid arthritis

Updated EULAR recommendations for management of rheumatoid arthritis

4 Jul 2013
Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

15 Jun 2013
Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

15 Jun 2013
Aarhus University study reveals that ordinary neutral running shoes function well for new runners

Aarhus University study reveals that ordinary neutral running shoes function well for new runners

15 Jun 2013
Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

14 Jun 2013
EULAR announces recipients of Meritorious Service Award

EULAR announces recipients of Meritorious Service Award

14 Jun 2013
Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

14 Jun 2013
Ischaemic heart disease patients at risk after 1 week of treatment

Ischaemic heart disease patients at risk after 1 week of treatment

14 Jun 2013
Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

14 Jun 2013
Data demonstrate benefits of nurse-led programme on patient self-management of RA

Data demonstrate benefits of nurse-led programme on patient self-management of RA

14 Jun 2013
Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

13 Jun 2013
AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

13 Jun 2013
Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

13 Jun 2013
Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

13 Jun 2013
Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

13 Jun 2013
Using Swiss ball improves walking performance and muscle strength in AS patients

Using Swiss ball improves walking performance and muscle strength in AS patients

13 Jun 2013
One-third of RA patients discontinue therapy within the first year of treatment

One-third of RA patients discontinue therapy within the first year of treatment

13 Jun 2013
Pregnancy carried to childbirth increases risk of ACPA-negative RA

Pregnancy carried to childbirth increases risk of ACPA-negative RA

13 Jun 2013
Study: Depression indicators are stronger predictors of work disability in early arthritis

Study: Depression indicators are stronger predictors of work disability in early arthritis

13 Jun 2013
Study on the development of internet-based physical activity intervention presented at EULAR 2013

Study on the development of internet-based physical activity intervention presented at EULAR 2013

13 Jun 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback